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1. Introduction 
The tri-block copolymers have more importance in 
fabrication of in situ gelling system for the delivery of 
various kinds of drugs, which can be administered by 
topical, opthalmic or parenteral routes. In situ gelling 
systems are the liquid formulations generating a solid or 
semisolid depot after administration (Packhaeuser C.B. 
et al. 2004, Eve Ruel-Garie´py and Jean-Christophe 
Leroux, 2004). These types of system have wide range of 
biomedical applications, such as drug delivery, tissue 
repair and cell encapsulation (Hoffman A. S., 2012, Qiu Y., 
and Park K., 2012). They are found to be more 
advantageous than the other traditional form of drug 
delivery systems. Pluronic® F127 is a category of non-
toxic, water soluble, biodegradable tri block copolymer, 
which composed of polyethylene oxide (PEO) 
/polypropylene oxide (PPO)/polyethylene oxide (PEO) 
units. The tri-block copolymers having application in 
formulation of in situ gelling system and these are 
known for exhibiting the sol-gel transition property 
under a certain temperature (Gilbert J.C. et al., 1987). 
The sol-gel transition increases the application of 
poloxamer in pharmaceutical field. The US FDA guideline 
has presented Pluronic® F127 as an safe, inactive, low 
toxic, biodegradable ingredient for different types of 
preparations because of their chemical inertness (e.g., 
This investigation presents a study on the effect of various polymers on gelling 
properties of tri-block (Pluronic®) copolymers and increasing the stability 
parameter of in situ gelling system by altering their composition. The tri-block 
copolymers finds their importance in fabrication of in situ gelling system for the 
delivery of various kinds of drugs, which can be administered by topical, 
ophthalmic or parenteral routes. Pluronic®, is a category of non-toxic, water 
soluble, biodegradable poly (ethylene oxide)/poly (propylene oxide)/poly 
ethylene oxide), tri-block copolymers which have application in formulation of 
various in situ gelling systems. This formulation undergo thermo-reversible 
gelation, where it exists as a free flowing liquid at low temperature and gels in 
the range of body temperature to form stable depot in aqueous environment. 
Gelling system was prepared according to the 'Cold Method' using different 
concentration of polymers (15% to 20% w/v) and subjected to the determination 
of gelation temperature (GT), viscosity study and effect of various polymers on 
the strength of gelation. Overall study on the gelation of system at particular 
temperature is the important parameter for formulation of in situ drug delivery 
system. It was established that addition of 0.5% w/v of HPMC K4M into gelling 
system make it stable for forming gel in the range of body temperature 
whereas methyl cellulose, carbopol 934P, and HPMC E-5 restrict the gel 
formation. 
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IV, inhalation, oral solution, suspension, ophthalmic or 
topical formulations) (Rowe R. et al., 2005). 
The hydrophobic group of tri-block copolymer can 
increases the sol-gel transition and minimal the 
concentration of polymer required for sol-gel transition 
(Niu G. et al., 2008). The rheological properties of 
Pluronic® show temperature dependence along with the 
chemical cross linking or entanglement of structures. As 
the internal cross linking of gelling system increases the 
sol-gel transition temperature decreases. Hence, the 
alteration in the cross linking capacity of copolymers the 
thermoreversible properties can also be improved. 
Simultaneously, the chemical cross linking of the tri 
block copolymer is responsible for the mechanical 
strength of the gel, lesser the cross linking soften the gel 
whereas greater the cross linking harder the gel. It 
means the increase in cross linking will improve the 
mechanical strength of the copolymers and ultimately 
the improvement in stability of gelling system whereas 
the gelation temperature of Pluronic® solution might be 
altered by addition of various polymeric materials as well 
as drug addition also shows effect on that (Dumortier G. 
et al., 2006). Thermally induced gelling systems show 
thermoreversible sol-gel transitions and are 
characterized by a lower critical solution temperature 
(LCST). They are liquid at room temperature and 
produce a gel at or above the LCST (Eliaz R. et al., 2000). 
Previously we prepared such type of 
thermoreversible drug delivery system by incorporation 
of cubosome containing docetaxel trihydrate which is an 
anticancer agent. The incorporation of the drug-loaded 
cubosomes into a thermoresponsive gelling system 
results in a slower and a prolonged drug release. 
According to the results of this study, a 
thermoresponsive depot system based on Pluronic® 
(F127 and F68), containing cubosomal DTX, can be 
developed for a controlled drug delivery. The cubosome 
containing thermoresponsive depot formulation was 
found to be free flowing at ambient temperature and 
formed a depot gel at body temperature (i.e. 37°C) 
(Rarokar N. et al., 2015). Hence, the cubosome based 
thermoreversible gel formulation may provide a possible 
solution to improve therapeutic efficiency of drug. Such 
systems are more useful for the delivery of cells or 
biopharmaceuticals that are susceptible to heat or 
organic solvents (Lee J. et al., 2006).  
The aqueous solution of Pluronic® is liquid at room 
temperature and converted into the semisolid gel at a 
higher temperature (Gang Wei et al. 2002). This 
thermogelling property of tri-block polymer is applied to 
prepare thermosesnsitive formulations, however some 
drawbacks like low mechanical strength and less stability 
make it unfavourable for application in commercial drug 
formulations. These problems lead to instability of in situ 
gelling system after administration. These issues can be 
sort out by altering the composition of gelling system 
using other copolymers along with the Pluronic® triblock 
copolymers. 
Aim of this study was to investigate the effect of 
various copolymers on gelling properties of Pluronic® 
triblock copolymer and increase the stability of in situ 
gelling system by altering their composition. Docetaxel 
trihydrate (DTX) was used as a model drug for this study 
and the effect of drug on the mechanical strength of 
gelling system was also studied. 
 
 
Fig. 1. Effect of copolymers on mechanical strength and stability of 
gelling system 
 
2. Materials and Methods  
2.1. Materials 
Docetaxel trihydrate was obtained as a gift sample 
from Scino Pharmaceuticals Pvt., Taiwan, Pluronic® F127 
was supplied by Research Lab Fine Chem Industries, 
Mumbai (India) and Pluronic® F68 obtained from 
Himedia Laboratory Pvt. Ltd. Mumbai (India), HPMC 
K4M was sourced from Otto Chemie Pvt. Ltd., Mumbai 
(India), HPMC E50, Carbopol 934P and Methyl Cellulose 
purchased from Loba Chemie Pvt. Ltd., Mumbai (India). 
All other chemicals used in this study were of analytical 
grade. 
 
2.2. Preparation of gelling system  
Gelling system was prepared according to the ‘Cold 
Method’ given in our previous article (Rarokar et al., 
2015) with slight modification. Pluronic® F127(15-20%w/v) 
and Pluronic® F68 (20-40%w/v) were weighed accurately 
and solubilised in 15 mL of distilled water in a beaker 
with continuous stirring on magnetic stirrer at a speed of 
500 rpm for 2hrs. The temperature of water maintained 
at 4±2°C. This mixture was then subjected to hydration at 
4-8 °C overnight to get uniform glassy solution. The 
copolymers like methylcellulose (0.3-1.0% w/v), carbopol 
934P (0.1-0.3%w/v), HPMC E-50 (0.3-1.0%) and HPMC K4M 
(0.3-1.0%w/v) was added separately with continuous 
stirring to prepared different batches. The weighed 
amount of drug (2%w/v) was dissolve in ethanol to make 
slurry. The drug slurry then mixed in the above 
homogeneous mixture. The final volume was made up 
and pH of the homogeneous mixture was adjusted to 7.0 
using triethanolamine, whereas mixture containing 
carbopol 934P was adjusted to pH 5.8. The prepared 
gelling system was then subject to different evaluation 
parameters to study the effect of concentration of 
different copolymers onto the thermal properties of 
Pluronic®. 
 
2.3. Drug-Excipient Compatibilty Studies 
a. Thermal Analysis 
The Differential scanning calorimetry (DSC) analysis 
of pure drug (DTX) and thier physical mixture with tri-
block copolymers were carried out using DSC Q20 (TA 
Instruments Inc. New Castle. DE). The approximately 5 
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mg sample wighed into each aluminium pans and was 
subject to heating at a rate of 10.0 °C/ min from 0 °C to 
400 °C. Nitrogen at a flow rate of 40 mL/min was used as 
a purge gas in DSC analyses. The results were analysed 
using the universal Analysis software version 4.5A, build 
4.5.0.5 (TA Instruments, Inc., New Castle, DE, USA). 
 
b. FTIR Spectroscopy 
To determine any possible interactions, the 
physical mixtures of the drug (DTX) and the tri-polymers 
were analyzed using the Fourier transformed infrared 
(FTIR) spectroscopy. Briefly, the samples were dried in a 
hot air oven at 50°C for 2 h. The samples were 
compressed under pressure of 10 t/nm2 to prepare 
circular KBr disks. The samples were scanned in the 
range of 400 to 4000 cm−1. The shifts in the spectra of 
the drug in the presence of polymers and other 
components were investigated to determine physical 
interactions between the drug and the polymers, if any.  
 
2.4. Viscosity Study of Polymers 
The viscosity of homogeneous mixture prepared 
with Pluronic®  tri-block copolymers were measured by 
using DV-E Brookfield viscometer using small sample 
adaptor with spindle 63 for 19.1± 0.5°C and LV2 spindle 
for 37± 0.5°C. The Various concentrations of Pluronic® 
F127 (15-20%w/v) and Pluronic® F68 (20-40%w/v) 
previously prepared homogeneous mixtures were 
poured into adaptor of viscometer and angular viscosity 
was increase3d gradually from 10 to 100 rpm with time 
interval of 6 seconds at each speed. Same process was 
repeated for the reverse speed (100 to 10) with a similar 
time interval of 6 seconds. The results were calculated 
for mean± standard deviation(n=3). Similarly experiment 
was repeated for gel at 36.7°C to determined the 
viscosity by using spindle LV 2. 
 
2.5. Measurement of Gelation Temperature by Tilting 
Method 
The gelation temperature measurement was done 
by previously reported 'Tilting Method' (Tirnaksiz et al., 
2005). The gelation temperature (GT) was recorded for 
different batches of homogeneous mixture of tri-block 
copolymer with different concentration with and 
without a model drug docetaxel trihydrate.  Aliquots (1 
mL) of prepared formulation were sealed and 
transferred to test tubes in the water bath at 4 ± 0.5°C 
then temperature was increased by 2 ± 0.5°C per step 
until 30 ± 0.5°C and then increment with 1°C in the region 
of sol-gel transition temperature. Gelation is the 
temperature that the meniscus would no longer move 
upon tilting through 90°. The method was very 
reproducible, giving coefficients of variation of less than 
2% (n = 4). 
 
3. Results 
3.1. Drug-Excipient Compatibility Studies 
a. Thermal Analysis 
The compatibility study of drug-polymer was studied by 
thermal analysis. DSC thermogram of docetaxel 
trihydrate exhibits a sharp endothermic peak at 227.82 °C 
which corresponds to its melting point. This peak of drug 
was not found in the DSC thermogram of polymer 
solution containing the drug. It indicates that the drug 
was uniformly dispersed into the gelling system and did 
not have any interaction with the other ingredients of 
gelling system. 
 
b. FTIR Spectroscopy 
Drug-polymer interaction was determined by the 
FTIR analysis, the reports were found to be concurrent 
with a reference spectrum of docetaxel trihydrate. 
Docetaxel showed prominent peaks at 711.68, 850.55, 
1099.35, 1168.78, 1245.93, 1712.67 and 3456.20 cm-1. The 
characteristic peaks confirmed the structure of 
docetaxel trihydrate. These peaks were retained in the 
other spectra of drug with the tri-block copolymers i.e. 
Pluronic® F127 / F68 and copolymers Methyl Cellulose, 
HPMC K4M, Carbopol 934P, HPMC E-50. The IR spectra 
did not show any shifting in the characteristic peaks of 
docetaxel as shown in Fig. 2. Hence, the FTIR study 
indicate that there were no positive evidences of 
interaction between docetaxel trihydrate and the 
employed polymers, this prove that drug is stable in 
presence of tri-block copolymers. 
 
 
(A) 
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(G) 
Fig. 2: FTIR spectra of Docetaxel trihydrate (A), Docetaxel trihydrate + Pluronic® F127 (B) and Docetaxel trihydrate + Pluronic® F68 (C), 
Docetaxel trihydrate+ HPMC K4M (D), Docetaxel trihydrate + Carbopol 934P (E), Docetaxel trihydrate + Methyl Cellulose (F), 
Docetaxel trihydrate + HPMC E-50 (G) 
 
3.2. Viscosity Study of Polymer 
Results of viscosity study of Pluronic® F127 and F68 
in different concentrations at various rpm shown are in 
the Table 1 and 2 respectively, it can be seen that as the 
concentration of Pluronic® F127 and F68 increases from 
15% to 20%, the viscosity of polymer solutions also 
increases. Simultaneously, from Fig. 3 and Fig. 4, it 
becomes clear that the increase in speed of spindle of 
Brookfield viscometer result into the decrease in 
viscosity of Pluronic®® F127 and F68 respectively. 
 
Table 1. Viscosity of Pluronic® F127 of Different Concentration at 
Various RPM 
 
Fig. 3. Viscosity study of different concentration of Pluronic® F127 
at various RPM 
 
Table 2. Viscosity of Pluronic® F68 of different concentration at 
various RPM 
Pluronic® F68 15% 16% 17% 18% 19% 20% 
Concentration w/v w/v w/v w/v w/v w/v 
RPM Viscocity (cP)   
10 38.2 36.3 44.3 43.2 48.1 50.7 
20 34.8 32.5 40.6 39.1 45.6 48.5 
30 29.7 26.2 35.2 33.8 40.7 43.3 
50 28.5 20.8 32.6 31.6 35.2 41.4 
60 18.1 16.3 26.7 27.4 33.3 35.9 
100 10.6 12.9 22.8 24.1 28.5 29.8 
 
Fig. 4. Viscosity study of different concentration of Pluronic® F68 at 
various RPM 
 
3.3. Gelation Teperature Study 
a. Gelation Temperature of Pluronic ® F127 
The GT was recorded for Pluronic® F127 gel alone 
(GT1) and with drug (GT2). The Table 3 presents that the 
GT1 and GT2 decreases with increase in polymer 
concentration from 15- 20 % w/v as depicted in Fig. 5. 
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Fig. 5. Determination of GT of different concentration of Pluronic® 
F127 with and without drug 
 
Table 3. Gelation temperature of Pluronic F127 of various 
concentrations with and without drug 
Sr. No. Concentration of GT (°C) GT with drug (°C) 
 PF127    without drug (DTX) 
 (% w/v)                          T1 T2 
01. 15 55 ± 0.23 60 ± 0.19 
02. 16 50 ± 0.45 54 ±0.33 
03. 17 45  + 0.31 50 + 0.28 
04. 18 40 + 0.26 45 + 0.18 
05. 19 37 + 0.34 42 + 0.31 
06. 20 28 + 0.35 35 + 0.25 
Value are mean±std. dev. (n=3) 
 
b. Gelation Temperature of Pluronic ® F68 
The Fig. 7 clears that the GT of Pluronic® F68 
without drug (GT3) decreases with increase in Pluronic® 
F68 concentration. While GT of Pluronic® F68 with drug 
Pluronic® F127 15% 16% 17% 18% 19% 20% 
Concentration w/v w/v w/v w/v w/v w/v 
RPM Viscocity (cP) 
10 41.1 38.3 44.2 45.2 50.6 52.8 
20 36.5 33.1 41.1 41.1 46.2 48.2 
30 31.4 28.1 38.6 39.2 42.1 44.5 
50 27.5 22.6 33.2 36.5 38.6 40.3 
60 19.6 19.1 26.5 31.7 35.2 37.2 
100 12.4 16.6 22.1 25.4 30.6 31.4 
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(GT4) was found to be slightly increased as compared to 
the Pluronic® F68 alone but decreased with increase in 
concentration of Pluronic® F68. 
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Fig.6. Determination of Gelation temperature of different 
concentration of Pluronic® F68 with and without drug 
 
Table 4. Gelation temperature of Pluronic F68 of various 
concentrations with and without drug 
Sr. No. Concentration of GT (°C) GT with drug (°C) 
 PF68    without drug (DTX) 
 (% w/v)                          T1 T2 
01. 20 70 + 0.33 78 ± 0.24 
02. 25 62 + 0.33 70 ± 0.21 
03. 30 50 + 0.33 66 ± 0.33 
04. 35 40 + 0.33 48 ± 0.25 
05. 38 37 + 0.33 44 ± 0.25 
06. 40 34 ± 0.33 38 ± 0.33 
 
c. Gelation Temprature of Pluronic ® F127 and Pluronic 
® F68 in Combination 
Pluronic® mixture of Pluronic® F127 and Pluronic® 
F68 were selected due to their thermo-gelling property. 
The GT of gelling system containing 15-18 % w/v 
concentration of Pluronic® F127 was found to be more by 
37 °C. Whereas, 20% w/v Pluronic® F127 shows the GT 
around 25°C, but it is not easy to administer due to 
increase in viscosity at the room temperature. The 
concentration of Pluronic® F68 at 25, 30, 33, 35 % w/v 
showed GT 63o, 48o, 40o, 37o C respectively. It also 
exhibit increased viscosity which makes it difficult to 
administer, so the combination of both the tri-block 
copolymer was used in various ratio for the preparation 
of gelling system. The results depicted in Table 5, shows 
that there was decrease in GT up to 30 °C for 18/20 ratio 
of Pluronic® F127 and Pluronic® F68. This makes the 
combination more suitable for preparation of gelling 
system. 
 
Table  5. GT of Pluronic® at various concentrations in combination 
(Pluronic® F127/ Pluronic® F68) with or without Docetaxel 
trihydrate. 
Sr. No. Concentration of GT (°C) GT with drug 
 PF127/PF68   (% without drug        Docetaxel trihydrate 
 w/v)  (°C) 
01. 15/10 45 + 0.31 50 + 0.32 
02. 15/15 39 + 0.42 44 + 0.37 
03. 15/20 35 + 0.35 39 + 0.41 
04. 16/10 40 + 0.33 44 + 0.34 
05. 16/15 38 + 0.33 43 ± 0.33 
06. 16/20 36 + 0.31 43 + 0.33 
07. 17/10 38 + 0.40 42 + 0.22 
08. 17/15 35 + 0.24 40 + 0.20 
09. 17/20 34 + 0.33 39 + 0.23 
10. 18/10 35 + 0.20 38 + 0.20 
11. 18/15 34 + 0.22 37 + 0.33 
12. 18/20 30 + 0.33 34 + 0.32 
Value are mean±std. dev. (n=3) 
 
3.4. Effect of Various Copolymers on the GT of Pluronic 
® F127 and Pluronic ® F68 
a. Effect of Methyl Cellulose on the GT of Pluronic ® 
F127 
The effect of concentration of methyl cellulose was 
investigated on the GT of Pluronic® F127 as depicted in 
Table 6. At the given concentration of Pluronic® F127 (15-
20% w/v), the GT decreases with increase in 
concentration of methyl cellulose from 0.3-1.0% w/v 
(Fig.7). The gelling solution prepared by 0.3% w/v methyl 
cellulose was found to be clear and transparent than 1.0% 
and 0.5% but have high GT. Whereas 0.5% methyl 
cellulose gives transparent solution with low GT as 
compared to the 0.3% and gelling solution containing 
1.0% methyl cellulose showed opaque appearance. 
 
Table 6. Effect of Methyl Cellulose concentration on GT of 
Pluronic® F127 
 
Pluronic® F127 
Concentration Methyl Cellulose Concentration 
 (% w/v)    
  0.3% 0.5% 1.0% 
Gelation temperature (°C) 
 15 52+ 0.33 46+ 0.33 41+ 0.33 
 16 46+ 0.33 40+ 0.33 38+ 0.33 
 17 42+ 0.33 35+ 0.33 32+ 0.33 
 18 35+ 0.33 30+ 0.33 28+ 0.33 
 20 32+ 0.33 26+ 0.33 22+ 0.33 
Values are mean±std. dev. (n=3) 
14 16 18 20 22
0
20
40
60
0.3 %
0.5 %
1.0 %
Pluronic F127 concentration % w/v
G
el
at
io
n
 T
em
p
er
at
u
re
 (
0 C
)
 
Fig. 7. Effect of various concentration of Methyl cellulose on GT of 
Pluronic® F127 
 
b. Effect of Methyl Cellulose on the GT of Pluronic ® 
F68 
On determination of effect of methyl cellulose on 
the GT of Pluronic® F68 having conce-ntration 20-40% 
w/v, it was found that as the concentration of methyl 
cellulose increases from 0.3 % w/v to 1.0% w/v the GT of 
Pluronic® F68 gradually decreases. However, when we 
compare these results with the GT of Pluronic® without 
any copolymer it was found that addition of 0.3- 1.0 % w/v 
concentration of methyl cellulose the GT is decreases by 
10°C. 
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Table 7. Effect of Methyl Cellulose concentration on GT of 
Pluronic® F68 
Values are mean±std. dev. (n=3) 
 
c. Effect of Carbopol 934P on the GT of Pluronic ® F127 
Carbopol 934P was used as gelling agent that 
increases the gelling strength of gelling system. The 
effect of concentration of carbopol 934P on the GT of 
Pluronic® F127 solution was investigated in the range of 
0.1-0.3% w/v as depicted in Table 7. The GT of Pluronic® 
F127 was found to be decreased with increase in 
concentration of carbopol 934P as shown in Fig.8. Since, 
increase in the temperature results into the sol-gel 
transformation of Pluronic® solution but the presence of 
carbopol restrict the gel formation after particular 
temperature and results in to the decreased in viscosity. 
 
Table 8. Effect of Carbopol 934P concentration on GT of Pluronic® 
F 127. 
 
Pluronic® F127 
Concentration Carbopol 934P Concentration 
 % w/v  (% w/v)  
  0.1% 0.2% 0.3% 
  Gelation temperature (°C) 
 15 46 + 0.33 42 + 0.33 39+ 0.33 
 17 43 + 0.33 41 + 0.33 40+ 0.33 
 18 39 + 0.33 34+ 0.33 37+ 0.33 
 20 29 + 0.33 28+ 0.33 26+ 0.33 
 22 26 + 0.33 24 + 0.33 22+ 0.33 
Values are mean±std. dev. (n=3) 
16 17 18 19 20 21 22 23 24
0
10
20
30
40
50
0.1 %
0.2 %
0.3 %
Pluronic F127 concentration % w/v
G
el
at
io
n
 T
em
p
er
at
u
re
 (0
C
)
 
Fig. 8. Effect of various concentration of Carbopol 934P on GT of 
Pluronic® F127 
 
d. Effect of Carbopol 934P Concentration on GT of 
Pluronic ® F68 
Carbopol 934P in the various concentration from 0.1 
to 0.3 % w/v when used as a copolymer with Pluronic® 
F68 for preparation of gelling system, it was found that 
as the concentration of carbopol 934P increases from 0.1 
to 0.3% w/v the GT of Pluronic® F68 gradually decreases 
up to certain extent but did not reaches around the 
normal body temperature. At higher concentration of 
Pluronic® F68 40% w/v and 0.3% w/v of Carbopol 934P 
gelling system shows GT about 40°C and the system was 
found to be more viscous. 
 
Table 9. Effect of Carbopol 934P concentration on GT of Pluronic® 
F68 
 
Pluronic® F68 
Concentration Carbopol 934P Concentration 
 % w/v                (% w/v)   
  0.1% 0.2% 0.3%  
  Gelation temperature (°C) 
 20 65 + 0.33 64 + 0.33 58+ 0.33  
 25 60 + 0.33 60 + 0.33 55+ 0.33  
 30 58 + 0.33 55 + 0.33 52+ 0.33  
 35 55 + 0.33 50 + 0.33 45+ 0.33  
 40 50 + 0.33 45 + 0.33 40 + 0.33  
Values are mean±std. Dev. (n=3) 
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Fig. 9. Effect of various concentration of Carbopol 934P on GT of 
Pluronic® F68 
 
e. Effect of HPMC K4M on the GT of Pluronic ® F127 
The effect of concentration of HPMC K4M on the 
GT of Pluronic® F127 solution (0.3, 0.5, 1.0% w/v) was 
investigated as revealed in the Table 8. At the given 
concentration of Pluronic® F127, the GT was decreased 
with increased in the concentration of HPMC K4M (Fig. 
10). The addition of 0.5%w/v HPMC K4M into the gelling 
system shows the GT in the range of body temperature 
and found to be stable at 37 °C for more than 6 hour 
which supports the data retrieved for improvement in 
gel strength of the gelling system of Pluronic® F127. 
 
Table 10. Effect of HPMC K4M concentration on GT of Pluronic® 
F127 
 
Pluronic® F127 
Concentration 
HPMC K4M 
Concentration 
 % w/v               (% w/v)  
  0.3% 0.5% 1.0% 
  Gelation temperature (°C) 
 15 46 + 0.33 37 + 0.33 30+ 0.33 
 16 44 + 0.33 35 + 0.33 28+ 0.33 
 18 40 + 0.33 26+ 0.33 18+ 0.33 
 20 34 + 0.33 21+ 0.33 Below 18 
 22 29 + 0.33 18± 0.33 Immediate 
Values are mean±std. Dev. (n=3) 
 
 
Pluronic® F68 
Concentration Methyl Cellulose Concentration 
 % w/v    
  0.3% 0.5% 1.0% 
  Gelation temperature (°C) 
 20 68+ 0.33 64+ 0.33 60+ 0.33 
 25 62+ 0.33 58+ 0.33 50+ 0.33 
 30 57+ 0.33 50+ 0.33 45+ 0.33 
 35 51+ 0.33 46+ 0.33 40+ 0.33 
 40 42+ 0.33 35+ 0.33 30+ 0.33 
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Fig.10. Effect of various concentration of HPMC K4M on GT of 
Pluronic® F127 
 
f. Effect of HPMC K4M Concentration on the GT of 
Plurinic ® F68 
The study to determine the effect of addition of 
copolymer on the different concentration of Pluronic® 
F68 revealed that the addition of HPMC K4M in the 
concentration of 0.3, 0.5 and 1.0 % w//v to the gelling 
system prepared by Pluronic® F68 results into the 
significantly decrease in GT upto the range of body 
temperature. This study shows that little increase in the 
concentration of HPMC K4M form stable gelling system 
with lower GT. 
 
Table 11. Effect of HPMC K4M concentration on GT of Pluronic® F68 
 
Pluronic® F68 
concentration  
HPMC K4M 
concentration 
 % w/v                     ( % w/v) 
  0.3% 0.5% 1.0% 
  Gelation temperature (°C) 
 20 65 + 0.33 60 + 0.33 55 + 0.33 
 25 60 + 0.33 55 + 0.33 50 + 0.33 
 30 55 + 0.33 50 + 0.33 45 + 0.33 
 35 50 + 0.33 45 + 0.33 40 + 0.33 
 40 45 + 0.33 40 + 0.33 35 + 0.33 
Values are mean±std. dev. (n=3) 
 
Fig.11. Effect of various concentration of HPMC K4M on GT of 
Pluronic® F68 
 
g. Effect of HPMC E-50 Concentration on Gelation 
Temperature of Pluronic ® F127 
Results depicted in the Table 12 shows that addition 
of HPMC E-50 in the concentration of 0.3 to 1.0 % w/v 
decrease the gelation temperature with increase in 
concentration but not significantly reach the range of 
body temperature. 
 
 
 
 
 
 
 
Table 12. Effect of HPMC E-50 concentration on GT of Pluronic® 
F127 
 
Pluronic® F127 
Concentration 
    HPMC E-50 
Concentration 
 % w/v                 ( % w/v)  
  0.3% 0.5% 1.0% 
  Gelation temperature (°C) 
 15 60 + 0.33 55 + 0.33 50 + 0.33 
 16 58 + 0.33 50 + 0.33 48 + 0.33 
 18 55 + 0.33 50 + 0.33 45 + 0.33 
 20 50 + 0.33 40 + 0.33 40 + 0.33 
 22 45 + 0.33 38 ± 0.33 35 + 0.33 
Values are mean±std. Dev. (n=3) 
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Fig.12. Effect of various concentration of HPMC E-50 on GT of 
Pluronic® F127 
 
h. Effect of HPMC E-50 Concentration on Gelation 
Temperature of Pluronic ® F68 
The effect of HPMC E-50 on the gelation 
temperature of Pluronic® F68 was found to be more 
significant as compared to their effect on Pluronic® F127. 
The increase in concentration of HPMC E-50 from 0.3 to 
1.0% w/v helps to decrease GT of gelling system, at every 
stage of increasing the concentration of HPMC E-50 the 
GT was decreased by 5°C and it reaches 30°C (). 
 
Table 13. Effect of HPMC E-50 concentration on GT of Pluronic® 
F68 
 
Pluronic® F68 
concentration  
HPMC E-50 
concentration 
 % w/v  (% w/v)  
  0.3% 0.5% 1.0% 
  Gelation temperature (°C) 
 20 60 + 0.33 55 + 0.33 50 + 0.33 
 25 55 + 0.33 50 + 0.33 45 + 0.33 
 30 50 + 0.33 45 + 0.33 40 + 0.33 
 35 45 + 0.33 40 + 0.33 35 + 0.33 
 40 40 + 0.33 35 ± 0.33 30 + 0.33 
Values are mean±std. Dev. (n=3) 
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Fig. 13. Effect of various concentration of HPMC E-50 on GT of 
Pluronic® F68 
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4. Discussion 
The formulation of thermoresponsive gel which 
forms stable gel at ambient temperature in the range of 
body temperature is very difficult task. To achieve the 
desired outcomes the gelation property of tri-block 
copolymers need to alter with the use of various 
polymers. The tri-block copolymers find their importance 
in fabrication of in situ gelling system for delivery of 
different kind of drugs, which can be administered by 
topical, ophthalmic or parenteral routs. Pluronic®, is a 
category of non-toxic, water soluble, biodegradable poly 
(ethylene oxide)/poly (propylene oxide)/polyethylene 
oxide), tri-block copolymers. The fabricated in situ gel 
shows thermo-reversible gelation which confirm by the 
existence of free flowing liquid at low temperature and 
undergo gelation to form stable depot at body 
temperature. The varying concentration of Pluronic® will 
show effect on viscosity of formulation which results 
into the change in release of drug from the gelling 
system. The increased viscosity of polymer solution is 
also prone to difficulty in the handling and 
administration of gelling system.  However, the gelation 
temperature of such a formulation is decreases as the 
concentration of Pluronic® increases but the viscosity 
still one of the important parameter to fabricate ideal 
formulation/gelling system.  
Though the Pluronic® is tri-block copolymer which 
having property to form gelling system, it requires other 
copolymers which may be synthetic, semisynthetic or 
natural. However the natural polymers are always 
beneficial for the human biology but because of lack of 
desired physicochemical properties we cannot use it at 
every stage of formulation. Whereas synthetic polymers 
like HPMC, carbopol, methyl cellulose etc. have their 
own issues regarding biodegradability and 
biocompatibility so semisynthetic polymers are good 
option for fabrication of potential drug delivery system. 
Here in this study we investigate the effect of 
copolymers on the gelling properties to fabricate ideal 
thermoreversible gel simultaneously the dependent 
variables such as gelation time and gelation temperature 
also studied by altering the concentration of 
copolymers.  
The previous literature shows that when we 
increase the temperature of polymer solution containing 
methyl cellulose beyond the critical temperature point 
(29± 2°C) the viscosity strongly increases and that results 
into the formation of thermoreversible gel the reason 
behind it the initiation of aggregation of particles to 
form pre-gel or loose gel domain showing shear thinning 
behaviour of the system. The author (Kobayashi et al., 
1999) did not discussed about the exact concentration of 
methylcellulose needed for formation of stable gel. 
When we used methyl cellulose as a copolymer or 
stabilizing agent along with the Pluronic® F127 and F68 
the different results were obtained. The results depicted 
in this study shows that the increase in concentration of 
methyl cellulose (0.3%w/v to 1.0%w/v) in gelling system 
prepared with Pluronic® F127 leads to the decrease in 
gelation temperature by 5°C. It forms opaque solution 
with increased viscosity and hence it was difficult to 
inject. This system might be useful for thermoreversible 
gel but it was not so useful to form injectable gelling 
system. The Pluronic® F68 shows somewhat different 
results when it was used in preparation of gelling system 
and the addition of 0.3-1.0% w/v methyl cellulose in to it 
results into the decreased in gelation temperature by 
10°C. 
The surprising results were obtained when the 
effect of carbopol 934 P on the thermoreversible 
properties of Pluronic® F127 and F68 was studied. The 
previous literature did not tell about the effect of 
carbopol 934P as a copolymer with Pluronics®. When the 
concentration of gelling system was alter by addition of 
0.1-0.3% w/v of carbopol 934P in gelling system prepared 
by use of Pluronic® F127, gelation temperature 
continuously goes on decreasing with increase in the 
concentration of carbopol 934P. The gelation 
temperature with increase in concentration of carbopol 
934P was found to be decreases but upto certain extent 
later on further addition it did not show any effect on 
gelation temperature, which may be due to the lack of 
water absorption sites on the surface of carbopol 
molecules. 
From the results obtained after studying thermal 
behaviour of Carbopol 934P it was clear that the 
increase in concentration of carbopol 934P restrict the 
gel formation and ultimately the sol-gel transition was 
hampered. This gives the clue to use of carbopol 934P as 
a stabilizer in fabrication of thermoreversible gel rather 
than their use to improve gelling strength. Same study 
was carried out with Pluronic® F68 and carbopol 934P in 
the concentration of 40% w/v and 0.3% w/v respectively 
which shows gelation at about 40°C and the system was 
found to be more viscous. This results proven the 
potential of Carbopol 934P to affect the sol-gel 
transition temperature which is exactly against the 
results depicted in previous literature (Asasutjarit R et 
al., 2011). 
Mondal S. et al. were used HPMC E50LV as a 
copolymer with sodium alginate at the concentration of 
1.5% w/w for the formulation of in situ ge and conclude 
that the use of HPMC E50LV in such a higher 
concentration gives transparent and clear free flowing 
gel which is very contraversial to the results obtained in 
our study (Mondal S. et al., 2012). In this study we 
revealed that the use of 1.0% w/v of HPMC E50 results 
into the formation of stiff gel which never been free 
flowing. 
The effect of HPMC E-50 on the GT of Pluronic® F68 
was found to be more significant as compared to their 
effect on Pluronic® F127 however it also having 
physicochemical drawbacks in relation to the thermal 
properties of the gelling system. The increase in 
concentration of HPMC E-50 from 0.3 to 1.0% w/v helps 
to decrease GT of gelling system by 5°C and it reaches 
30°C but further increase in the concentration results 
into the increase in viscosity with opaque appearance. 
This more viscous solution did not show desired results 
in comparison with HPMC K4M. Hence, the use of HPMC 
E-50 as a copolymer was not so advantageous in 
fabrication of thermoreversible gel formulations. 
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The investigation of effect of addition of HPMC 
K4M to the thermoreversible gelling system for altering 
the gelling properties of Pluronic® F127 and F68 revealed 
that the 0.5% w/v of HPMC K4M shows better results 
than the previously added copolymers. The 0.5% w/v of 
HPMC K4M shows desire gelling temperature. However, 
other copolymer shows either higher or lower GT. In 
addition to that the introduction of HPMC K4M in 0.5% 
w/v concentration results into the formation of stable 
gel with improved gelling strength i.e. upto 6h the 
similar results were obtained when gelling system 
prepared with Pluronic® F68 but having issue with the 
gelation temperature which was found to be more than 
the ambient temperature. The slightly increase in the 
concentration of HPMC K4M tends to form stable gel 
and lower GT. Hence the ultimate aim of the study was 
achieved by use of HPMC K4M as a copolymer in 
combination with Pluronic®. 
 
5. Conclusion 
Gelation temperature of the gelling system plays 
important role in the formulation of thermoresponsive 
depot system. As these formulations have GT near to the 
body temperature it opens the door for forming depot 
after insertion into the body, either in muscle or beneath 
the skin. So, it is necessary to optimize the gelation 
temperature of gelling system to form a potential depot 
system. In this study it was revealed that GT1 and GT2 of 
Pluronic® F127 decrease with increase in polymer 
concentration. However, addition of 0.5% w/v of HPMC 
K4M into gelling system make it stable for forming gel in 
the range of body temperature whereas carbopol 934P 
and methyl cellulose restrict the gel formation. Besides 
the effect of addition of copolymer on the gelation 
temperature of gelling system, the role of model drug on 
the GT of system is also one of the major aspects as far 
as depot formulation is concern. Regardless of the other 
concentrations of the drug and polymers, the addition of 
0.2% w/v docetaxel trihydrate increases the GT of 
polymer solution by 2-3°C. On the other hand presence of 
0.5% w/v of HPMC K4M drops down the GT upto ambient 
temperature, which is the decisive factor for formation 
of in situ gel or depot system. Hence the prepared 
gelling system and the results obtained during this study 
can be utilized for the formulation of a potential depot 
forming drug delivery system. 
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